BELGIUM, March 12, 2025 — LaCAR MDx Technologies, a leader in automated newborn screening solutions, has acquired the assets and technology of Baebies, Inc.’s newborn screening division. This move expands LaCAR’s capabilities and accelerates its entry into the U.S. market.
Founded in 2013 in Liège, Belgium, LaCAR aims to make diagnostics faster and more accessible. The company specializes in newborn screening and pharmacogenetics, offering solutions to laboratories worldwide.
“We’re excited about this acquisition, as it strengthens our position in the newborn screening market,” said Arnaud Allaer, CEO of LaCAR. The deal includes Baebies’ innovative SEEKER solution, which screens for four Lysosomal Storage Diseases in under three hours.
The acquisition will:
- Enhance LaCAR’s technology with digital microfluidics.
- Expand Baebies’ products outside the U.S.
- Strengthen LaCAR’s presence in the U.S. market.
Both companies are committed to a smooth integration, ensuring high service levels for their customers. Richard West, CEO of Baebies, emphasized, “This partnership will drive innovation in newborn screening and deliver lasting value to our communities.”
In short, LaCAR’s merger with Baebies is a major step toward making newborn screening even more innovative and globally accessible. Quite the power move!
Related topics:
